These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 19319930
1. Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels. Succurro E, Marini MA, Grembiale A, Lugarà M, Andreozzi F, Sciacqua A, Hribal ML, Lauro R, Perticone F, Sesti G. Diabetes Metab Res Rev; 2009 May; 25(4):351-6. PubMed ID: 19319930 [Abstract] [Full Text] [Related]
2. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Abdul-Ghani MA, Williams K, DeFronzo R, Stern M. Diabetes Care; 2006 Jul; 29(7):1613-8. PubMed ID: 16801587 [Abstract] [Full Text] [Related]
3. The level of 2-h post-challenge glucose is an independent risk factor of carotid intima-media thickness progression in Korean type 2 diabetic patients. Kim HJ, Ahn CW, Kang ES, Myoung SM, Cha BS, Won YJ, Lim SK, Kim KR, Huh KB, Lee HC. J Diabetes Complications; 2007 Jul; 21(1):7-12. PubMed ID: 17189868 [Abstract] [Full Text] [Related]
4. Glucose turnover and intima media thickness of internal carotid artery in type 2 diabetes offspring. Anderwald C, Pfeiler G, Nowotny P, Anderwald-Stadler M, Krebs M, Bischof MG, Kozakova M, Luger A, Pacini G, Roden M, Waldhäusl W. Eur J Clin Invest; 2008 Apr; 38(4):227-37. PubMed ID: 18339003 [Abstract] [Full Text] [Related]
5. Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia an underestimated evil? Temelkova-Kurktschiev T, Henkel E, Schaper F, Koehler C, Siegert G, Hanefeld M. Exp Clin Endocrinol Diabetes; 2000 Apr; 108(2):93-9. PubMed ID: 10826515 [Abstract] [Full Text] [Related]
6. Relationship of glucose concentrations with PAI-1 and t-PA in subjects with normal glucose tolerance. Heldgaard PE, Sidelmann JJ, Hindsberger C, Olivarius Nde F, Henriksen JE, Gram J. Diabet Med; 2006 Aug; 23(8):887-93. PubMed ID: 16911627 [Abstract] [Full Text] [Related]
8. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus. Ozeki N, Hara K, Yatsuka C, Nakano T, Matsumoto S, Suetsugu M, Nakamachi T, Takebayashi K, Inukai T, Haruki K, Aso Y. Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051 [Abstract] [Full Text] [Related]
10. Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110 mg/dL threshold. Andreozzi F, Succurro E, Mancuso MR, Perticone M, Sciacqua A, Perticone F, Sesti G. Diabetes Metab Res Rev; 2007 Oct; 23(7):547-50. PubMed ID: 17311284 [Abstract] [Full Text] [Related]
13. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program. Boronat M, Saavedra P, Varillas VF, Wagner AM, López-Plasencia Y, Alberiche MP, Nóvoa FJ. Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785 [Abstract] [Full Text] [Related]
14. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance]. Kang Y, Lu JM, Sun JF, Li CL, Wang XL, Zhang XQ, Lü ZH, Dou JT, Mu YM. Zhonghua Yi Xue Za Zhi; 2009 Mar 17; 89(10):669-72. PubMed ID: 19595059 [Abstract] [Full Text] [Related]
15. Serum insulin-like growth factor binding protein-1: an improvement over other simple indices of insulin sensitivity in the assessment of subjects with normal glucose tolerance. Borai A, Livingstone C, Zarif H, Ferns G. Ann Clin Biochem; 2009 Mar 17; 46(Pt 2):109-13. PubMed ID: 19164337 [Abstract] [Full Text] [Related]
16. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels. Sahin M, Karatas M, Sahin M, Ertugrul D, Kulaksizoğlu M, Dogruk A, Gokcel A, Tutuncu NB, Guvener ND, Kutlu M. Minerva Endocrinol; 2008 Dec 17; 33(4):289-96. PubMed ID: 18923366 [Abstract] [Full Text] [Related]
17. The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects. Anderwald C, Anderwald-Stadler M, Promintzer M, Prager G, Mandl M, Nowotny P, Bischof MG, Wolzt M, Ludvik B, Kästenbauer T, Pacini G, Luger A, Krebs M. Diabetes Care; 2007 Sep 17; 30(9):2374-80. PubMed ID: 17595351 [Abstract] [Full Text] [Related]
18. No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects. Lerche S, Soendergaard L, Rungby J, Moeller N, Holst JJ, Schmitz OE, Brock B. Clin Endocrinol (Oxf); 2009 Oct 17; 71(4):500-6. PubMed ID: 19094067 [Abstract] [Full Text] [Related]
19. Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Succurro E, Marini MA, Arturi F, Grembiale A, Lugarà M, Andreozzi F, Sciacqua A, Lauro R, Hribal ML, Perticone F, Sesti G. Atherosclerosis; 2009 Nov 17; 207(1):245-9. PubMed ID: 19410252 [Abstract] [Full Text] [Related]
20. Ghrelin, glucose homeostasis, and carotid intima media thickness in kidney transplantation. Genís BB, Granada ML, Alonso N, Lauzurica R, Jiménez JA, Barluenga E, Homs M, Pastor MC, Salinas I, Quintero JC, Sanmartí A, Romero R. Transplantation; 2007 Nov 27; 84(10):1248-54. PubMed ID: 18049109 [Abstract] [Full Text] [Related] Page: [Next] [New Search]